CSHCN 2008 > Physician > Benefits and Limitations

   
 

24.3.22.3 Fluocinolone Acetonide Intravitreal Implant (Retisert)

Procedure code 1-J7311 is a benefit for the CSHCN Services Program for clients 12 years of age and older. Procedure code 1-J7311 is only considered for reimbursement with a posterior uveitis (36320) diagnosis of more than six months in duration and only when the condition has been unresponsive to oral or systemic medication treatment. Prior authorization is required.

Fluocinolone acetonide intravitreal implant is a corticosteroid indicated for the treatment of chronic noninfectious uveitis affecting the posterior segment of the eye. The implant is surgically implanted and is designed to release fluocinolone acetonide over approximately 30 months.


Texas Medicaid & Healthcare Partnership
CPT only copyright 2007 American Medical Association. All rights reserved.
PreviousNextIndex